Bone marrow (BM) examination, serum/urine protein electrophoresis (PEP), and immunofixation electrophoresis (IFE) are useful for diagnosing multiple myeloma and evaluating treatment response in patients with multiple myeloma. 1,2 However, the diagnosis of nonsecretory multiple myeloma (NSM), which occurs in approximately 1%-5% of all patients with multiple myeloma,